Download PDF
Dtsch Med Wochenschr 2011; 136(8): e20-e23
DOI: 10.1055/s-0031-1272980
Kommentar | Commentary
Medizinisches Publizieren
© Georg Thieme Verlag KG Stuttgart · New York

CONSORT 2010: Aktualisierte Leitlinie für Berichte randomisierter Studien im Parallelgruppen-Design

CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trialsK. F. Schulz1 , D. G. Altman2 , D. Moher3
  • 1Family Health International, Research Triangle Park, North Carolina, United States of America
  • 2Centre for Statistics in Medicine, University of Oxford, Wolfson College, Oxford, United Kingdom
  • 3Ottawa Methods Centre, Clinical Epidemiology Program, Ottawa Hospital Research Institute, Department of Epidemiology and Community Medicine, University of Ottawa, Ottawa,Canada
Further Information

Publication History

Publication Date:
10 February 2011 (online)

Also available at
   Permissions and Reprints

Corrected by:

CONSORT 2010: Aktualisierte Leitlinie für Berichte randomisierter Studien im Parallelgruppen-DesignDtsch Med Wochenschr 2011; 136(15): e26-e26
DOI: 10.1055/s-0031-1272983

Die Autoren der bearbeiteten Übersetzung aus dem Englischen sind: M. H. Pittler1, A. Blümle1, J. J. Meerpohl1,2, G. Antes1

1Deutsches Cochrane Zentrum, Abteilung für Medizinische Biometrie und Statistik, Universitätsklinikum Freiburg, Freiburg
2Pädiatrische Hämatologie und Onkologie, Zentrum für Kinder- und Jugendmedizin, Universitätsklinikum Freiburg, Freiburg

Literatur

  • 1 Begg C, Cho M, Eastwood S. et al . Improving the quality of reporting of randomized controlled trials. The CONSORT statement.  JAMA. 1996;  276 637-639
    Search in Google Scholar
  • 2 Boutron I, Moher D, Altman D G, Schulz K F, Ravaud P. Extending the CONSORT statement to randomized trials of nonpharmacologic treatment: explanation and elaboration.  Ann Intern Med. 2008;  148 295-309
    Search in Google Scholar
  • 3 Campbell M K, Elbourne D R, Altman D G. CONSORT statement: extension to cluster randomised trials.  BMJ. 2004;  328 702-708
    Search in Google Scholar
  • 4 Chan A W, Hrobjartsson A, Haahr M T, Gotzsche P C, Altman D G. Empirical evidence for selective reporting of outcomes in randomized trials: comparison of protocols to published articles.  JAMA. 2004;  291 2457-2465
    Search in Google Scholar
  • 5 De Angelis C, Drazen J M, Frizelle F A. et al . Clinical trial registration: a statement from the International Committee of Medical Journal Editors.  Ann Intern Med. 2004;  141 477-478
    Search in Google Scholar
  • 6 Dwan K, Altman D G, Arnaiz J A. et al . Systematic review of the empirical evidence of study publication bias and outcome reporting bias.  PLoS ONE. 2008;  3 e3081
    Search in Google Scholar
  • 7 Gagnier J J, Boon H, Rochon P. et al . Reporting randomized, controlled trials of herbal interventions: an elaborated CONSORT statement.  Ann Intern Med. 2006;  144 364-367
    Search in Google Scholar
  • 8 Glasziou P, Meats E, Heneghan C, Shepperd S. What is missing from descriptions of treatment in trials and reviews?.  BMJ. 2008;  336 1472-1474
    Search in Google Scholar
  • 9 Hollis S, Campbell F. What is meant by intention to treat analysis? Survey of published randomised controlled trials.  BMJ. 1999;  319 670-674
    Search in Google Scholar
  • 10 Hopewell S, Clarke M, Moher D. et al . CONSORT for reporting randomised trials in journal and conference abstracts.  Lancet. 2008;  371 281-283
    Search in Google Scholar
  • 11 Hopewell S, Clarke M, Moher D. et al . CONSORT for reporting randomized controlled trials in journal and conference abstracts: explanation and elaboration.  PLoS Med. 2008;  5 e20
    Search in Google Scholar
  • 12 Ioannidis J P, Evans S J, Gotzsche P C. et al . Better reporting of harms in randomized trials: an extension of the CONSORT statement.  Ann Intern Med. 2004;  141 781-788
    Search in Google Scholar
  • 13 Lexchin J, Bero L A, Djulbegovic B, Clark O. Pharmaceutical industry sponsorship and research outcome and quality: systematic review.  BMJ. 2003;  326 1167-1170
    Search in Google Scholar
  • 14 Moher D, Hopewell S, Schulz K F. et al . CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials.  BMJ. 2010;  340 c869
    Search in Google Scholar
  • 15 Moher D, Schulz K F, Altman D G, Gruppe f dC. Das CONSORT Statement: Überarbeitete Empfehlungen zur Qualitätsverbesserung von Reports randomisierter Studien im Parallel-Design.  Dtsch med Wochenschr. 2004;  129 T16-T20
    Search in Google Scholar
  • 16 Montori V M, Devereaux P J, Adhikari N K. et al . Randomized trials stopped early for benefit: a systematic review.  JAMA. 2005;  294 2203-2209
    Search in Google Scholar
  • 17 Nuovo J, Melnikow J, Chang D. Reporting number needed to treat and absolute risk reduction in randomized controlled trials.  JAMA. 2002;  287 2813-2814
    Search in Google Scholar
  • 18 Piaggio G, Elbourne D R, Altman D G, Pocock S J, Evans S J. Reporting of noninferiority and equivalence randomized trials: an extension of the CONSORT statement.  JAMA. 2006;  295 1152-1160
    Search in Google Scholar
  • 19 Sackett D L. Commentary: Measuring the success of blinding in RCTs: don’t, must, can’t or needn’t?.  Int J Epidemiol. 2007;  36 664-665
    Search in Google Scholar
  • 20 Schulz K F, Altman D G, Moher D. for the CONSORT Group . CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials.  BMJ. 2010;  340 c332
    Search in Google Scholar
  • 21 Schulz K F, Grimes D A. Blinding in randomised trials: hiding who got what.  The Lancet. 2002;  359 696-700
    Search in Google Scholar
  • 22 Zwarenstein M, Treweek S, Gagnier J J. et al . Improving the reporting of pragmatic trials: an extension of the CONSORT statement.  BMJ. 2008;  337 a2390
    Search in Google Scholar

Dr. Gerd Antes

Deutsches Cochrane Zentrum
Abteilung für Medizinische Biometrie und Statistik
Institut für Medizinische Biometrie und Medizinische Informatik
Universitätsklinikum Freiburg

Berliner Allee 29

79110 Freiburg

Email: antes@cochrane.de